QX005N

Moderate to severe AD

Phase II

Phase II clinical trial of QX005N for AD

QX001S

Adult moderate to severe plaque Ps

phase III

A multicenter, randomized, double-blind, parallel controlled phase III clinical study comparing the efficacy and safety of QX001S and Ustekinumab in adult patients with moderate to severe plaque Ps

QX006N

SLE

Phase I

Phase I clinical trial of single administration of QX006N in healthy individuals

QX002N

AS

Phase II

Phase II clinical study evaluating the efficacy and safety of QX002N in patients with active ankylosing spondylitis

QX002N

AS

Phase I

Phase I clinical study evaluating subcutaneous and intravenous injection of QX002N

QX004N

Ps

Phase I

Phase I clinical trial of single administration of QX006N in healthy individuals